Magazine Article | January 4, 2022

The Future Of Life Sciences Manufacturing And The Supply Chain

Source: Life Science Leader

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

We witnessed some amazing accomplishments by the biopharmaceutical industry last year.

Just think about all those clinical trials that were executed for the multiple vaccines that we now have access to in world-record time. But without the ability to: a) manufacture the supply necessary to conduct these trials, b) manage the transportation of these temperature-sensitive products to the point where they need to be administered, and c) scale up capacity to make the billions of doses necessary to inoculate the world, then nothing would have happened. In other words, the life sciences manufacturing and supply chains are everything when it comes to helping patients. In this edited transcript from our August 2021 executive virtual roundtable (EVR), perspectives on life sciences manufacturing and the supply chain are provided by Bryan Butman, Ph.D., head of CMC, Precigen; Louise Perry, SVP tech ops, Solid Biosciences; and Tim Valko, head of global manufacturing supply chain, Atara Biotherapeutics.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader